Navigation Links
Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
Date:8/29/2007

CAMBRIDGE, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation at the Thomas Weisel Partners 2007 Healthcare Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The presentation will review recent events, clinical pipeline updates, and upcoming milestones. The presentation will be delivered at 8:35 a.m. ET on Friday, September 7, 2007 from the Four Seasons Hotel in Boston, MA. The presentation will be archived for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.

Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.

Contact:

Kyle Kuvalanka

'/>"/>
SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. OpGen adds Thomas Pyle and James Ogle to board of directors
2. Jellyfish partners for sales tracking technology
3. GE Healthcare partners with UNC on breast cancer imaging research
4. Manufacturing partnership will move into biotech and biomedical spaces
5. Fergus joins Baird Venture Partners, Caden Bio
6. Avolte Venture Partners reaches capital goal
7. NimbleGen partners with UK biotech firm
8. Big pharma seeks Wisconsin biotech partnerships
9. Thompson in partnership to build ethanol plant
10. Johnson Controls partners on car satellite linkup
11. Doyle, WARF announce partnership to lure stem cell companies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...
(Date:11/19/2009)..., NEW YORK, Nov. 19 N...hat it has sent the following letter to its shareh...ctober 30, 2009, of China Biopharmaceuticals Holdi... company based in the People,s Republic of China. ...t in Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s p...
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNewsw...have filed on November 16th, 2009 Flibanserin in t...dyskinesia in Parkinson,s,disease for orphan drug ...ncy,(EMEA). Levodopa-induced dyskinesia is a compl...inson,s and a serious burden to some of those,affe...
(Date:11/19/2009)... World,s Top Gene Synthesis Com...m (IGSC) to Coordinate Best Practices in Risk Redu...t of Worldwide Gene Synthesis Capacity , ...of the world’s leading gene synthesis compan... a common screening protocol to promote biosecurit...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...pril 22 ACCESS PHARMACEUTICALS, INC. (OTC Bulle...), its proprietary polymer-based oral mucositis pr...ece and the Nordic countries by its European comme...pharmaceutical company dedicated to the provision ...critical care. , , Under a license from Access P...
...Can Influence New Product Development and Innovati...t end-user study from Frost & Sullivan,s Pharm...riety of critical dynamics of drug delivery approa...ians, nurses and patients provided insight on fact...e vs. office administration parameters, and barrie...
...HAI, April 22 /PRNewswire-Asia-FirstCall/ -- China... "the Company"), a leading Chinese firm,specializi...eting and,distribution of probiotics products, tod...nong Group ("Dabeinong") to supply probiotics as b...er the initial purchase order, which has already b...
Other Biology Technology:Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 2Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 3Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males 2Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males 3China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed 2China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed 3
(Date:11/23/2009)...lied mathematicians dissected the morphology of th...stic long leaf with a saddle-like arc midsection a...ple cause of the lily,s fan-like shapeelastic rela...growthwas revealed by using an equally simple tech... postdoctoral student at Harvard,s School of Engin...
(Date:11/23/2009)...ay matters to forest trees dealing with drought, a...m led by Professor Malcolm Campbell, University of... and colleagues in the department of cell and syst...lizing on their previous work to decode the genome...w poplar trees use their 45,000 genes to respond t...
(Date:11/23/2009)...ociety says that western lowland gorillas living i...e "mother lode" of more than 125,000 gorillas disc...ed by growing humans activity in the region. , T...s adjacent to the southwest border of Lac Tl Commu...igh densities of the great apes still exist in the...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Time of day matters to thirsty trees, U of T researcher discovers 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Blood Test Shows Statistically Significant Association With Alzheimers Disease 28AD 29 May Predict Conversion of Mild Cognitive Impairment to AD 51872 1Blood Test Shows Statistically Significant Association With Alzheimers Disease 28AD 29 May Predict Conversion of Mild Cognitive Impairment to AD 51872 2Sinovac Adjourns 2008 Annual General Meeting 13056 1Sinovac Adjourns 2008 Annual General Meeting 13056 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 1AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 3
...or it, a survival guide for bacteria might include...st from going apoptotic." A host,s cells can respo...grammed cell death. For bacteria that pass directl...he bacteria are highly virulent and induce too muc...re they,re able to jump ship, thus hurting the bac...
... professor who last year won a Presidential Award,...g the promise of stem cell research one step close...of biomedical engineering at NJIT, is researching ...esearch will help diabetics whose impaired bones w...ls, in combination with allografts ?donated bone t...
...ersity of Illinois at Chicago have identified a me... based on the sensitivity of cellular DNA to enzym...al., "Chromatin sensitivity to Alu I restriction e...y the extracellular matrix and cytoskeleton," appe...l of Pathology and is accompanied by a commentary....
Other Biology News:The Bacteria's guide to survival 2NJIT Presidential Award winner takes stem cell research another step 2NJIT Presidential Award winner takes stem cell research another step 3Study of genomic DNA leads to new advances in cancer diagnostics 2
Acrylamide/Bis 19:1 40% (w/v) solution from Ambion
DONKEY SERUM (WITH 0.09% AZIDE) from AbD Serotec
Mouse Anti-Mouse XBP-1 Monoclonal Antibody, Unconjugated, Clone F-4 from Santa Cruz Biotechnology, Inc.
Mouse Anti-Cytokeratin 1 - 8 Monoclonal Antibody, Unconjugated, Clone AE3 from Abcam
Biology Products: